Comment regarding benefit in phase 1 oncology trials.
Publication
, Journal Article
Morse, M
Published in: Clin Trials
2008
Duke Scholars
Published In
Clin Trials
DOI
ISSN
1740-7745
Publication Date
2008
Volume
5
Issue
6
Start / End Page
626
Location
England
Related Subject Headings
- Treatment Outcome
- Statistics & Probability
- Risk Assessment
- Patient Education as Topic
- Neoplasms
- Informed Consent
- Humans
- Disclosure
- Clinical Trials, Phase I as Topic
- 5203 Clinical and health psychology
Citation
APA
Chicago
ICMJE
MLA
NLM
Morse, M. (2008). Comment regarding benefit in phase 1 oncology trials. Clin Trials, 5(6), 626. https://doi.org/10.1177/1740774508098682
Morse, Michael. “Comment regarding benefit in phase 1 oncology trials.” Clin Trials 5, no. 6 (2008): 626. https://doi.org/10.1177/1740774508098682.
Morse M. Comment regarding benefit in phase 1 oncology trials. Clin Trials. 2008;5(6):626.
Morse, Michael. “Comment regarding benefit in phase 1 oncology trials.” Clin Trials, vol. 5, no. 6, 2008, p. 626. Pubmed, doi:10.1177/1740774508098682.
Morse M. Comment regarding benefit in phase 1 oncology trials. Clin Trials. 2008;5(6):626.
Published In
Clin Trials
DOI
ISSN
1740-7745
Publication Date
2008
Volume
5
Issue
6
Start / End Page
626
Location
England
Related Subject Headings
- Treatment Outcome
- Statistics & Probability
- Risk Assessment
- Patient Education as Topic
- Neoplasms
- Informed Consent
- Humans
- Disclosure
- Clinical Trials, Phase I as Topic
- 5203 Clinical and health psychology